Article Topic
WHO Alert: Counterfeit Cancer Medicines Reported in Europe
Information provided to WHO by AstraZeneca, the genuine manufacturer of IMFINZI, has confirmed that the products identified in this Alert are falsified. Laboratory analysis of samples of the falsified IMFINZI have been carried out by AstraZeneca. The analysis confirmed that the vials of the falsified product contained no active pharmaceutical ingredient.
[...]January 13, 2025: WHO warns about a fake cancer drug with English packaging
WHO reported a fake cancer treatment. This year’s Notorious Markets report focused on fake online pharmacies. Board member Andrea Thomas urged fraternities to stock Narcan.
[...]Complaint, USA v Rui-Siang Lin (Incognito Market)
United States District Court Southern District of New York USA v Rui-Siang Lin Complaint Filed January 26, 2024 Read the document.
[...]FDA Alert: Recall Issued on “Herbal” Diet Pill Containing Prescription and OTC Drug Ingredients
FDA analysis has found these products to contain undeclared Furosemide, Dexamethasone and Chlorpheniramine. Furosemide was found at 5.24 mg/g or 1.84 mg/capsule. Dexamethasone was found at 2.22 mg/g or 0.780 mg/capsule. Chlorpheniramine was found at 4.38 mg/g or 1.54 mg/capsule.
[...]Prescription Drug Affordability Board Activity through December 18, 2024
Prescription Drug Affordability Board Activity through December 18, 2024 Activities Summary Colorado: The Prescription Drug Affordability Board (PDAB) met on December 6, 2024 to hear and discuss public comment before proposing and approving revisions to policy and procedures around affordability reviews. The PDAB updated the state’s Prescription Drug Affordability Review Board and Advisory Council (PDAAC)…
[...]December 16, 2024: Black market medicine in Texas and Tennessee
Two new cases involving black market medicine in Texas and Tennessee, and CPB seized thousands of pills in Laredo.
[...]December 9, 2024: Lawsuit against Snap to proceed
The lawsuit against Snap may proceed and the ADA issued a statement about compounded GLP-1 medicines.
[...]JAMA Personal Drug Importation Correction
PSM’s executive director submitted the following correction to the Journal of the American Medical Association (JAMA) in December 2024: International online pharmacies are illegal, and an unacceptable cost-saving strategy Shabbir Safdar Executive Director, The Partnership for Safe Medicines JAMA’s October 21, 2024 Special Communication, “Strategies to Help Patients Navigate High Prescription Drug Costs,” by Hussain…
[...]Government’s Restitution Memo, USA v Lorik Papyan
United States District Court Northern District of California USA v Lorik Papyan Government’s Restitution Memo Filed November 4, 2024 Read the document and Gilead Sciences’ Victim Impact Statement.
[...]Order re: Payment of Restitution, USA v Lorik Papyan
United States District Court Northern District of California USA v Lorik Papyan Order re: Payment of Restitution Filed November 22, 2024 Read the document.
[...]